Armocida et al. [22] showed that a Ki-67 index >20% was associated with shorter progression-free survival, which corroborates with Liang et al. [23] study that observed a correlation between the Ki-67 index and first-year mortality in 335 glioma patients. The gene discussed is MKI67; the disease is central nervous system cancer.